StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3027% above fair value
$396.69−7.33 (-1.81%)

Close on Nov 19, 2026Market cap $27.63BP/E 44.5Yield 0.22%

West Pharmaceutical Services free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

West Pharmaceutical Services's free cash flow for the twelve months ending Sep 30, 2026 was $453.40M, up 19.6% year over year. For fiscal 2025 it was $468.90M, up 69.6% from the year before. Over ten years it grew 19.2% a year on average. The highest annual figure on record is $468.90M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$468.90M+69.6%
FY2024Dec 31, 2024$276.40M-33.3%
FY2023Dec 31, 2023$414.50M-5.7%
FY2022Dec 31, 2022$439.40M+32.9%
FY2021Dec 31, 2021$330.60M+10.9%
FY2020Dec 31, 2020$298.10M+23.8%
FY2019Dec 31, 2019$240.80M+30.9%
FY2018Dec 31, 2018$183.90M+38.8%
FY2017Dec 31, 2017$132.50M+169.3%
FY2016Dec 31, 2016$49.20M-39.1%
FY2015Dec 31, 2015$80.80M+13.8%
FY2014Dec 31, 2014$71.00M+3.5%
FY2013Dec 31, 2013$68.60M+22.3%
FY2012Dec 31, 2012$56.10M+58.9%
FY2011Dec 31, 2011$35.30M-47.5%
FY2010Dec 31, 2010$67.20M+104.9%
FY2009Dec 31, 2009$32.80M–
FY2008Dec 31, 2008-$3.60M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$150.40M+12.3%
Q2 FY2026Jun 30, 2026$80.80M-20.7%
Q1 FY2026Mar 31, 2026$47.20M-18.8%
Q4 FY2025Dec 31, 2025$175.00M+105.4%
Q3 FY2025Sep 30, 2025$133.90M+35.5%
Q2 FY2025Jun 30, 2025$101.90M+57.3%
Q1 FY2025Mar 31, 2025$58.10M+110.5%
Q4 FY2024Dec 31, 2024$85.20M-34.7%
Q3 FY2024Sep 30, 2024$98.80M-26.4%
Q2 FY2024Jun 30, 2024$64.80M-30.9%
Q1 FY2024Mar 31, 2024$27.60M-50.7%
Q4 FY2023Dec 31, 2023$130.40M-4.0%
Q3 FY2023Sep 30, 2023$134.30M+20.9%
Q2 FY2023Jun 30, 2023$93.80M-12.3%
Q1 FY2023Mar 31, 2023$56.00M-34.4%
Q4 FY2022Dec 31, 2022$135.90M+61.2%
Q3 FY2022Sep 30, 2022$111.10M-11.0%
Q2 FY2022Jun 30, 2022$107.00M+22.3%
Q1 FY2022Mar 31, 2022$85.40M+151.2%
Q4 FY2021Dec 31, 2021$84.30M-7.4%
Q3 FY2021Sep 30, 2021$124.80M+75.5%
Q2 FY2021Jun 30, 2021$87.50M-21.2%
Q1 FY2021Mar 31, 2021$34.00M+36.0%
Q4 FY2020Dec 31, 2020$91.00M+32.3%
Q3 FY2020Sep 30, 2020$71.10M-6.9%
Q2 FY2020Jun 30, 2020$111.00M+44.5%
Q1 FY2020Mar 31, 2020$25.00M+33.0%
Q4 FY2019Dec 31, 2019$68.80M+59.3%
Q3 FY2019Sep 30, 2019$76.40M+23.4%
Q2 FY2019Jun 30, 2019$76.80M+24.3%
Q1 FY2019Mar 31, 2019$18.80M+10.6%
Q4 FY2018Dec 31, 2018$43.20M-16.9%
Q3 FY2018Sep 30, 2018$61.90M+49.2%
Q2 FY2018Jun 30, 2018$61.80M+10.8%
Q1 FY2018Mar 31, 2018$17.00M–
Q4 FY2017Dec 31, 2017$52.00M+114.0%
Q3 FY2017Sep 30, 2017$41.50M–
Q2 FY2017Jun 30, 2017$55.80M–
Q1 FY2017Mar 31, 2017-$16.80M–
Q4 FY2016Dec 31, 2016$24.30M–

More West Pharmaceutical Services figures

See a number that looks wrong?